1. Home
  2. MRNA vs PR Comparison

MRNA vs PR Comparison

Compare MRNA & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • PR
  • Stock Information
  • Founded
  • MRNA 2010
  • PR 2015
  • Country
  • MRNA United States
  • PR United States
  • Employees
  • MRNA N/A
  • PR N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • PR Oil & Gas Production
  • Sector
  • MRNA Health Care
  • PR Energy
  • Exchange
  • MRNA Nasdaq
  • PR Nasdaq
  • Market Cap
  • MRNA 9.8B
  • PR 9.9B
  • IPO Year
  • MRNA 2018
  • PR 2016
  • Fundamental
  • Price
  • MRNA $27.89
  • PR $13.06
  • Analyst Decision
  • MRNA Hold
  • PR Strong Buy
  • Analyst Count
  • MRNA 17
  • PR 15
  • Target Price
  • MRNA $42.40
  • PR $18.29
  • AVG Volume (30 Days)
  • MRNA 12.3M
  • PR 15.5M
  • Earning Date
  • MRNA 11-06-2025
  • PR 11-05-2025
  • Dividend Yield
  • MRNA N/A
  • PR 4.60%
  • EPS Growth
  • MRNA N/A
  • PR 18.42
  • EPS
  • MRNA N/A
  • PR 1.54
  • Revenue
  • MRNA $3,078,000,000.00
  • PR $5,085,699,000.00
  • Revenue This Year
  • MRNA N/A
  • PR $7.48
  • Revenue Next Year
  • MRNA $9.75
  • PR $1.34
  • P/E Ratio
  • MRNA N/A
  • PR $8.49
  • Revenue Growth
  • MRNA N/A
  • PR 16.37
  • 52 Week Low
  • MRNA $23.15
  • PR $10.01
  • 52 Week High
  • MRNA $59.73
  • PR $16.33
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 58.77
  • PR 39.09
  • Support Level
  • MRNA $26.91
  • PR $12.32
  • Resistance Level
  • MRNA $28.99
  • PR $12.76
  • Average True Range (ATR)
  • MRNA 1.22
  • PR 0.37
  • MACD
  • MRNA 0.35
  • PR -0.08
  • Stochastic Oscillator
  • MRNA 76.78
  • PR 18.75

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: